Tennis Elbow Treatment Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Tennis Elbow Treatment Market Analysis
The tennis elbow treatment market is expected to register a CAGR of 4.1% during the forecast period.
During the COVID-19 pandemic, the tennis elbow treatment market encountered a setback due to the imposed lockdown, deferral, and cancellation of a range of sports events that led to a decline in sports and related other injuries. In March 2020, Tokyo Olympics and Paralympics were postponed to 2021 by the International Olympic Committee. Similarly, an article published in February 2022 recorded around a 34.6% decrease in sports-related emergency department visits in 2020. In addition, as per the same source, the majority of the sports-related ED visits were of patients aged 22 years (55.7%). Such incidents negatively impacted market growth. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations during this period.
All these factors have affected product sales with declined hospital visits during the initial phases of the pandemic. Additionally, the manufacturing of tennis elbow pharmaceuticals was also affected during the first wave of the pandemic, which negatively impacted market growth in 2020.
However, in 2021, the tennis elbow treatment industry showed a sturdy recovery, owing to an increasing relaxation in restrictions leading to a rise in the number of sports activities globally. As per the data published by the NSC Injury Facts, in July 2021, the prevalence of sports and recreational injuries increased by 20% in the year 2021. Thus, the increasing number of sport-related injuries among the population is expected to increase the market growth over the forecast period. This is expected to grow further in the upcoming years.
The rising burden of sports-related and tennis elbow injuries is the key factor driving the market growth. For instance, as per an article published in February 2022, about 8.6 million athletes suffer from sports-related injuries each year in the United States. As per the data published by the NSC Injury Facts, in July 2021, about 3.2 million people received treatment in the emergency department for injuries involving sports and recreational equipment such as exercise, cycling, and basketball. This is expected to increase the risk of tennis elbow injuries, which is anticipated to increase the demand for effective treatment, propelling market growth.
Additionally, an article published in BMC Sports, Science, Medicine and Rehabilitation in January 2022 found that the administration of hyaluronic acid in patients suffering from tennis elbow has reduced the pain within three months. Thus, the use of hyaluronic acid injection is considered the best option for treating tennis elbow pain as compared to surgery and other treatment options. This is anticipated to boost market growth over the forecast period.
The rising geriatric population is also expected to increase the market growth. For instance, as per an article published in NCBI in August 2022, elderly people are at high risk of elbow injuries and traumatic fractures. The symptoms of tennis elbow usually appear at the age of 40 to 60 years. Also, as per 2022 statistics published by UNPFA, about 64% of the population living in Germany was between the ages 15-64 years in 2022, and 22% of the population was aged 65 years and above in 2022. Thus, the high number of elderly people living in the country is expected to develop elbow-related injuries as the muscles are more susceptible to overuse in middle and older age. This is anticipated to fuel the demand for effective treatment options and hence boost the market growth.
However, the sluggish commercialization of new effective therapies is expected to hamper the market growth over the forecast period.
Tennis Elbow Treatment Market Trends
This section covers the major market trends shaping the Tennis Elbow Treatment Market according to our research experts:
Braces by Non-surgical Therapies Segment is Expected to Showcase Significant Growth over the Forecast Period.
The braces segment is expected to witness significant growth in the tennis elbow market during the forecast period owing to the factors such as the rising incidence of tennis elbow and sport-related injuries and the pain caused by it as well as high product availability.
As per an article published in NCBI in July 2022, it has been observed that counterforce bracing is a popular treatment for tennis elbow. As per the same source, counterforce braces can significantly reduce pain by applying pressure to the forearm extensor muscles and then preventing and distributing tension on the damaged extensor carpi radialis brevis (ECRB) origin and promoting self-healing.
Also, 2021 data published by biomechanical research showed that using a counterforce brace can considerably reduce pain frequency and intensity for two to twelve weeks and enhance elbow function at 26 weeks. In addition to counterforce braces, cock-up wrist braces can reduce wrist extension and ECRB tendon activation during regular activities, allowing the wounded tendon to heal. Thus, such studies and benefits are expected to increase the demand and adoption of braces among the target population, propelling segment growth.
The technological advancements in braces and the introduction of bionic elbow braces are also expected to increase the market growth. There are several elbow braces and bands available in the market that helps in reducing elbow pain and healing. For instance, DonJoy Performance Bionic Elbow Brace II provides maximum hinged support for elbow hyperextension, Tommy John ligament injury, and dislocated elbow for football, lacrosse, rugby, and basketball players.
Also, Hykes elbow support compression sleeves braces are used to relieve pain from tendonitis arthritis, strains, joint discomfort, sprains, fatigue, and post-injury rehabilitation. It is also used for post-surgery recovery or preventing sports injuries, for daily care, and for various sports, including baseball, football, badminton, volleyball, baseball, basketball, hockey, CrossFit, cricket, weightlifting, powerlifting, squats, golf, shuttle, hockey, tennis, and racquetball.
Thus, owing to the aforementioned factors, the segment studied is expected to grow significantly during the forecast period.
The North America Dominates the Market and is Expected to Continue the During the Forecast Period
North America is expected to dominate the tennis elbow market during the forecast period. The factors attributing to the market growth are the increasing burden of tennis elbow and sport-related injuries, the presence of well-established healthcare infrastructure, high healthcare spending, and growing patient awareness regarding lateral epicondylitis.
In addition, the rising geriatric population in the region who are more prone to develop elbow-related issues due to their weaker bones is also expected to increase the demand for effective treatment options such as pain-relieving drugs, physical therapies, and others. This is anticipated to fuel market growth.
The rising burden of sport-related and tennis elbow injuries among the population is increasing in the region due to the increasing number of sports events and competitions, especially in the United States. This is anticipated to increase the demand for various treatment options that helps in reducing pain as well as increase the rate of healing. For instance, as per the data published by GJEL, in June 2022, the five most dangerous sports that caused the highest number of injuries in 2021 are basketball with 2,823 injury cases, American football with 1,719, soccer with 1,289, baseball with 347 and boxing with 247 injury cases.
As per the same source, sprains and strains, which accounted for 37% of all basketball injuries, compared to 29% for soccer and 26% for American football, were found to be the most common injuries for the three most dangerous sports in the US. The ligament discomfort was cited as the primary injury in 23% of cases for basketball and soccer. Thus, the high number of sports injuries, sprains, and strain issues increase the risk of elbow dislocation or fractures. This is expected to increase the demand for medications and surgery, thereby bolstering the market growth.
Furthermore, as per a news published in September 2021, Korsh Jafarnia presented the results of its study at the American Academy of Orthopaedic Surgeons Annual Meeting, which showed that hyaluronic acid injection is effective in relieving pain and improving function in patients with chronic tennis elbow. Also, the patients who received hyaluronic acid injections experienced significant improvements in VAS pain scores, patient-rated tennis elbow evaluation, and QuickDASH scores. Thus, such studies are expected to increase the demand for medications for treating elbow injuries, thereby boosting market growth.
Thus, owing to the aforementioned factors, the studied market is expected to grow significantly during the forecast period.
Tennis Elbow Treatment Industry Overview
The tennis elbow treatment market is consolidated in nature. Various companies are striving to gain market share by adopting competitive strategies, such as joint ventures and research partnerships. Some key players operating in the market include 3M, AKSIGEN, BTL, DJO Global Inc., Johari Digital, Ossur Corporate, OttoBock HealthCare, Teikoku Pharma USA Inc., Veritas Health LLC, and Zimmer Biomet. The players are constantly involved in strategic initiatives, such as new product launches, technological advancements, regional expansion, and mergers and acquisitions in order to gain deeper penetration.
Tennis Elbow Treatment Market Leaders
-
DJO Global, Inc.
-
Teikoku Pharma USA, Inc
-
Zimmer Biomet
-
3M
-
AKSIGEN
*Disclaimer: Major Players sorted in no particular order
Tennis Elbow Treatment Market News
- In April 2022, Chen Yueh announced that it is conducting a Phase III clinical study to find out functional and electromyographical changes after platelet-rich plasma and dextrose injection in chronic lateral epicondylitis, in Taiwan.
- In March 2022, the Istanbul university announced that it is conducting a clinical trial to compare the effectiveness of platelet-rich plasma, saline (0.9 NACI), and betametazon injection techniques in the treatment of elbow lateral epicondylitis. The trials are expected to end on January 2023.
Tennis Elbow Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Cases of Lateral Epicondylitis and Sport-related Injuries
- 4.2.2 Increase in Target Population Base
- 4.2.3 Technological Advancement and Favorable Reimbursement
-
4.3 Market Restraints
- 4.3.1 Sluggish Commercialization of New Effective Therapies
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Treatment Type
- 5.1.1 Surgical Therapies
- 5.1.1.1 Arthroscopic Surgery
- 5.1.1.2 Open Surgery
- 5.1.2 Non-surgical Therapies
- 5.1.2.1 Extracorporeal Shock Wave Therapy
- 5.1.2.2 Braces
- 5.1.2.3 Medications
- 5.1.2.4 Physical Therapies
-
5.2 Geography
- 5.2.1 North America
- 5.2.1.1 United States
- 5.2.1.2 Canada
- 5.2.1.3 Mexico
- 5.2.2 Europe
- 5.2.2.1 Germany
- 5.2.2.2 United Kingdom
- 5.2.2.3 France
- 5.2.2.4 Italy
- 5.2.2.5 Spain
- 5.2.2.6 Rest of Europe
- 5.2.3 Asia-Pacific
- 5.2.3.1 China
- 5.2.3.2 Japan
- 5.2.3.3 India
- 5.2.3.4 Australia
- 5.2.3.5 South Korea
- 5.2.3.6 Rest of Asia-Pacific
- 5.2.4 Middle East and Africa
- 5.2.4.1 GCC
- 5.2.4.2 South Africa
- 5.2.4.3 Rest of Middle East and Africa
- 5.2.5 South America
- 5.2.5.1 Brazil
- 5.2.5.2 Argentina
- 5.2.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3M
- 6.1.2 AKSIGEN
- 6.1.3 BTL
- 6.1.4 DJO Global Inc.
- 6.1.5 Johari Digital
- 6.1.6 Ossur Corporate
- 6.1.7 OttoBock HealthCare
- 6.1.8 Teikoku Pharma USA Inc.
- 6.1.9 Veritas Health LLC
- 6.1.10 Zimmer Biomet
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityTennis Elbow Treatment Industry Segmentation
As per the scope of the report, tennis elbow (lateral epicondylitis) is a painful condition caused by the repetitive motion of the arms and elbow. A kind of tendinitis, the condition involves swelling of tendons and is identified on medical examination. Lateral epicondylitis (tennis elbow) is an inflammatory condition observed usually in tennis players, baseball players, swimmers, carpenters, plumbers, and anyone who repeats an arm motion over and over.
The tennis elbow treatment market is segmented by treatment type (surgical therapies (arthroscopic surgery and open surgery) and non-surgical therapies (extracorporeal shock wave therapy, braces, medications, and physical therapies) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across significant regions globally. The report offers the value (in USD million) for the above segments.
| By Treatment Type | Surgical Therapies | Arthroscopic Surgery |
| Open Surgery | ||
| By Treatment Type | Non-surgical Therapies | Extracorporeal Shock Wave Therapy |
| Braces | ||
| Medications | ||
| Physical Therapies | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Tennis Elbow Treatment Market Research FAQs
What is the current Tennis Elbow Treatment Market size?
The Tennis Elbow Treatment Market is projected to register a CAGR of 4.10% during the forecast period (2024-2029)
Who are the key players in Tennis Elbow Treatment Market?
DJO Global, Inc. , Teikoku Pharma USA, Inc, Zimmer Biomet , 3M and AKSIGEN are the major companies operating in the Tennis Elbow Treatment Market.
Which is the fastest growing region in Tennis Elbow Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Tennis Elbow Treatment Market?
In 2024, the North America accounts for the largest market share in Tennis Elbow Treatment Market.
What years does this Tennis Elbow Treatment Market cover?
The report covers the Tennis Elbow Treatment Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Tennis Elbow Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Lateral Epicondylitis Treatment Industry Report
Statistics for the 2024 Lateral Epicondylitis Treatment market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Lateral Epicondylitis Treatment analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
